enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - léky na obstrukční onemocnění dýchacích cest, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - léky na obstrukční onemocnění dýchacích cest, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
arcoxia 30mg potahovaná tableta
n.v. organon, oss array - 16348 etorikoxib - potahovaná tableta - 30mg - etorikoxib
arcoxia 60mg potahovaná tableta
n.v. organon, oss array - 16348 etorikoxib - potahovaná tableta - 60mg - etorikoxib
arcoxia 90mg potahovaná tableta
n.v. organon, oss array - 16348 etorikoxib - potahovaná tableta - 90mg - etorikoxib